바이오마린제약(주)
MX ˙ BMV ˙ US09061G1013
SecurityMX:BMRN / BioMarin Pharmaceutical Inc.
InstitutionComerica Bank
Latest Disclosed Ownership62,650 shares
Latest Disclosed Value $ 3,723,311
Comerica Bank reports 7.84% decrease in ownership of BMRN / BioMarin Pharmaceutical Inc.

On January 29, 2026 - Comerica Bank filed a 13F-HR form disclosing ownership of 62,650 shares of BioMarin Pharmaceutical Inc. (MX:BMRN) valued at $3,723,311 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 14, 2025 disclosing 67,976 shares of BioMarin Pharmaceutical Inc.. This represents a change in shares of -7.84% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-01-29 2025-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 62,650 -5,326 -7.84 3,723 1.14 0.0149
2025-11-14 2025-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 67,976 -9,841 -12.65 3,682 -13.94 0.0138
2025-08-14 2025-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 77,817 -5,214 -6.28 4,278 -27.13 0.0166
2025-05-14 2025-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 83,031 21,520 34.99 5,869 45.16 0.0246
2025-02-14 2024-12-31 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 61,511 -3,716 -5.70 4,043 -11.80 0.0163
2025-02-14 2024-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 61,511 -3,716 4,043 0.0135
2024-11-14 2024-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 65,227 -7,991 -10.91 4,585 -23.95 0.0181
2024-08-15 2024-06-30 13F BIOMARIN PHARMACEUTICAL COMMON 09061G101 73,218 66,161 937.52 6,028 878.57 0.0251
2024-05-16 2024-03-31 13F BIOMARIN PHARMACEUTICAL COMMON 09061G101 7,057 -296 -4.03 616 -12.99 0.0027
2024-02-14 2023-12-31 13F BIOMARIN PHARMACEUTICAL COMMON 09061G101 7,353 2,037 38.32 709 50.64 0.0033
2023-11-21 2023-09-30 13F BIOMARIN PHARMACEUTICAL COMMON 09061G101 5,316 -29,334 -84.66 470 0.0024
2023-08-22 2023-06-30 13F BIOMARIN PHARMACEUTICAL EQU 09061G101 34,650 31,528 1,009.87 0 0.0066
2023-01-26 2022-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 3,122 305 10.83 0 -100.00 0.0027
2022-10-28 2022-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 2,817 371 15.17 253 19.91 0.0021
2022-08-02 2022-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 2,446 -3,261 -57.14 211 -54.13 0.0017
2022-04-27 2022-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 5,707 -5,225 -47.80 460 -50.43 0.0033
2022-02-18 2021-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 10,932 -8,998 -45.15 928 -36.83 0.0068
2021-11-22 2021-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 19,930 -4,646 -18.90 1,469 -20.08 0.0088
2021-08-26 2021-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 24,576 -1,833 -6.94 1,838 -11.63 0.0110
2021-04-28 2021-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 26,409 -588 -2.18 2,080 -12.42 0.0124
2021-01-28 2020-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 26,997 2,838 11.75 2,375 26.87 0.0151
2020-10-30 2020-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 24,159 -192 -0.79 1,872 -39.75 0.0136
2020-07-31 2020-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 24,351 -15 -0.06 3,107 31.04 0.0239
2020-05-01 2020-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 24,366 10,146 71.35 2,371 95.63 0.0217
2020-02-07 2019-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 14,220 694 5.13 1,212 29.07 0.0092
2019-10-31 2019-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 13,526 55 0.41 939 -15.48 0.0074
2019-08-02 2019-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 13,471 797 6.29 1,111 -5.04 0.0089
2019-05-02 2019-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 12,674 2,614 25.98 1,170 23.42 0.0095
2019-02-06 2018-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 10,060 -36 -0.36 948 -6.32 0.0081
2018-11-01 2018-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 10,096 565 5.93 1,012 2.12 0.0082
2018-08-01 2018-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 9,531 2,489 35.35 991 68.25 0.0069
2018-05-01 2018-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 7,042 -142 -1.98 589 -10.21 0.0042
2018-02-02 2017-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 7,184 -137 -1.87 656 9.33 0.0044
2017-11-06 2017-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 7,321 -37 -0.50 600 -9.37 0.0043
2017-08-03 2017-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 7,358 76 1.04 662 -5.56 0.0050
2017-05-03 2017-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 7,282 183 2.58 701 13.61 0.0053
2017-02-08 2016-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 7,099 7,099 -2.51 617 -11.98 0.0049
2015-11-12 2015-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 0 -3,062 -100.00 0 -100.00
2015-08-13 2015-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 3,062 3,062 0.00 418 0.0018
2014-08-12 2014-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 0 -13,699 -100.00 0 -100.00
2014-05-15 2014-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 13,699 9 0.07 934 -3.01 0.0072
2014-02-11 2013-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 13,690 -10,903 -44.33 963 -45.78 0.0075
2013-11-12 2013-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 24,593 -3,567 -12.67 1,776 13.12 0.0124
2013-08-13 2013-06-30 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 28,160 28,160 1,570 0.0128
2013-08-08 2013-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 139,011 7,749
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.